Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial [Clinical Sciences]
Conclusions—
The risk of cardiovascular death, stroke, or systemic embolism is higher in anticoagulated patients with permanent AF than in those with nonpermanent AF, regardless of preexisting heart failure.
Source: Stroke - Category: Neurology Authors: Senoo, K., Lip, G. Y. H., Lane, D. A., Buller, H. R., Kotecha, D. Tags: Thrombosis risk factors Clinical Sciences Source Type: research
More News: Atrial Fibrillation | Cardiology | Cardiovascular | Coumadin | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Failure | Hypertension | Neurology | Stroke | Thrombosis | Warfarin